Role of Polyadenylation in Nucleocytoplasmic Transport of mRNA

REFERENCES

• Bernstein, P., S. W. Peltz, and J. Ross. 1989. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9:659–670.
   PubMed Web of Science ®Google Scholar
• Birnstiel, M. K., M. Busslinger, and K. Strub. 1985. Transcription termination and 3′ processing: the end is in site. Cell 41:349–359.
   PubMed Web of Science ®Google Scholar
• Bogerd, H. P., R. A. Fridell, S. Madore, and B. R. Cullen. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485–494.
   PubMed Web of Science ®Google Scholar
• Cahill, K. B., and G. G. Carmichael. 1989. Deletion analysis of the poly-omavirus late promoter: evidence for both positive and negative elements in the absence of early proteins. J. Virol. 63:3634–3642.
   PubMedGoogle Scholar
• Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV rev depends upon recognition of splice sites. Cell 59:789–795.
   PubMedGoogle Scholar
• Crowl, R., K. Ganguly, M. Gordon, R. Conroy, M. Schaber, R. Kramer, G. Shaw, F. Wong-Staal, and E. P. Reddy. 1985. HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients. Cell 41:979–986.
   PubMedGoogle Scholar
• Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375–394.
   PubMedGoogle Scholar
• Dahm, S. C., and O. Uhlenbeck. 1991. Role of divalent metal ions in the hammerhead RNA cleavage reaction. Biochemistry 30:9464–9469.
   PubMed Web of Science ®Google Scholar
• Dargemont, C., and L. C. Kuhn. 1992. Export of mRNA from microinjected nuclei of Xenopus laevis oocytes. J. Cell Biol. 118:1–9.
   PubMedGoogle Scholar
• Eckner, R., W. Ellmeier, and M. L. Birnstiel. 1991. Mature messenger RNA 3′ end formation stimulates RNA export from the nucleus. EMBO J. 10:3513–3522.
   PubMed Web of Science ®Google Scholar
• Emerman, M., R. Vazeux, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57:1155–1165.
   PubMedGoogle Scholar
• Fabre, E., and E. C. Hurt. 1994. Nuclear transport. Curr. Opin. Cell Biol. 6:335–342.
   PubMedGoogle Scholar
• Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807–817.
   PubMed Web of Science ®Google Scholar
• Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495–1499.
   PubMed Web of Science ®Google Scholar
• Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475–483.
   PubMed Web of Science ®Google Scholar
• Fischer, U., S. Meyer, M. Teufer, C. Heckel, R. Luhrmann, and G. Raut-mann. 1994. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:4105–4112.
   PubMedGoogle Scholar
• Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (London) 376:530–533.
   PubMed Web of Science ®Google Scholar
• Hamm, J., and I. W. Mattaj. 1990. Monomethylated cap structures facilitate RNA export from the nucleus. Cell 63:109–118.
   PubMed Web of Science ®Google Scholar
• Hope, T. J., X. Huang, D. McDonald, and T. G. Parslow. 1990. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl. Acad. Sci. USA 87:7787–7791.
   PubMedGoogle Scholar
• Izaurralde, E., and I. W. Mattaj. 1995. RNA export. Cell 8155:153–159.
   Google Scholar
• Izaurralde, E., J. Stepinski, E. Darzynkiewicz, and I. W. Mattaj. 1992. A cap binding protein that may mediate nuclear export of RNA polymerase II-transcribed RNAs. J. Cell Biol. 118:1287–1295.
   PubMed Web of Science ®Google Scholar
• Jackson, R. J., and N. Standart. 1990. Do the poly(A) tail and 3′ untranslated region control messenger RNA translation. Cell 62:15–24.
   PubMed Web of Science ®Google Scholar
• Kalland, K. H., A. M. Szilvay, K. A. Brokstad, W. Saetrevik, and G. Haukenes. 1994. The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol. Cell. Biol. 14:7436–7444.
   PubMedGoogle Scholar
• Kjems, J., and P. A. Sharp. 1993. The basic domain of rev from human immunodeficiency virus type-1 specifically blocks the entry of U4/U6 u5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:4769–4776.
   PubMedGoogle Scholar
• Klietzien, R. F. 1980. Nucleocytoplasmic transport of RNA: the effect of 3′-deoxyadenosine triphosphate on RNA release from isolated nuclei. Biochem. J. 192:753–759.
   PubMedGoogle Scholar
• Krug, R. M. 1993. The regulation of export of mRNA from nucleus to cytoplasm. Curr. Opin. Cell Biol. 5:944–949.
   PubMedGoogle Scholar
• Legrain, P., and M. Rosbash. 1989. Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 57:573–583.
   PubMed Web of Science ®Google Scholar
• Lichtler, A., N. L. Barrett, and G. G. Carmichael. 1992. Simple, inexpensive preparation of T1/T2 ribonuclease suitable for use in RNase protection experiments. BioTechniques 12:231–232.
   PubMedGoogle Scholar
• Liu, Z., D. B. Batt, and G. G. Carmichael. 1994. Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. Proc. Natl. Acad. Sci. USA 91:4258–62.
   PubMedGoogle Scholar
• Lu, X., J. Heimer, D. Rekosh, and M.-L. Hammarskjold. 1990. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl. Acad. Sci. USA 87:7598–7602.
   PubMedGoogle Scholar
• Luo, Y., and G. G. Carmichael. 1991. Splice site choice in a complex transcription unit containing multiple inefficient polyadenylation signals. Mol. Cell. Biol. 11:5291–5300.
   PubMedGoogle Scholar
• Malim, M. H., S. Bohnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 rev trans-activator-derivation of a trans-dominant repressor of rev function. Cell 58:205–214.
   PubMed Web of Science ®Google Scholar
• Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180–6189.
   PubMedGoogle Scholar
• Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev transactivator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338:254–257.
   PubMed Web of Science ®Google Scholar
• Malim, M. H., D. F. McCarn, L. S. Tiley, and B. R. Cullen. 1991. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:4248–4254.
   PubMed Web of Science ®Google Scholar
• Marzluff, W. F. 1992. Histone 3′ ends: essential and regulatory functions. Gene Expression 2:93–97.
   PubMedGoogle Scholar
• Meyer, B. E., and M. H. Malim. 1994. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1538–1547.
   PubMedGoogle Scholar
• Niwa, M., C. C. MacDonald, and S. M. Berget. 1992. Are vertebrate exons scanned during splice-site selection? Nature (London) 360:277–280.
   PubMed Web of Science ®Google Scholar
• Olsen, H. S., A. W. Cochrane, P. J. Dillon, C. M. Nalin, and C. A. Rosen. 1990. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1357–1364.
   PubMed Web of Science ®Google Scholar
• Pastori, R. L., J. E. Moskaitis, S. W. Buzek, and D. R. Schoenberg. 1992. Differential regulation and polyadenylation of transferrin mRNA in Xenopus liver and oviduct. J. Steroid Biochem. Mol. Biol. 42:649–657.
   PubMedGoogle Scholar
• Peterlin, B. M., P. A. Luciq, P. J. Barr, and M. D. Walker. 1986. Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 83:9734–9738.
   PubMedGoogle Scholar
• Pfeifer, K., B. E. Weiler, D. Ugarkovic, M. Bachmann, H. C. Schroder, and W. E. Muller. 1991. Evidence for a direct interaction of Rev protein within nuclear envelope mRNA-translocation system. Eur. J. Biochem. 199:53–64.
   PubMedGoogle Scholar
• Qiu, Y., and R. M. Krug. 1994. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68:2425–2432.
   PubMedGoogle Scholar
• Robberson, B. L., G. J. Cote, and S. M. Berget. 1990. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10:84–94.
   PubMed Web of Science ®Google Scholar
• Ruhl, M., M. Himmelspach, G. M. Bahr, F. Hammerschmid, H. Jaksche, B. Wolff, H. Aschauer, G. K. Farrington, H. Probst, D. Bevec, and J. Hauber. 1993. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell. Biol. 123:1309–1320.
   PubMed Web of Science ®Google Scholar
• Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82:495–506.
   PubMedGoogle Scholar
• Wahle, E. 1995. 3′-end cleavage and polyadenylation of mRNA precursors. Biochim. Biophys. Acta 1261:183–194.
   PubMedGoogle Scholar
• Zapp, M. L., T. J. Hope, T. G. Parslow, and M. R. Green. 1991. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for the arginine-rich binding motif. Proc. Natl. Acad. Sci. USA 88:7734–7738.
   PubMed Web of Science ®Google Scholar